Laura D'Erasmo

Pubblicazioni

Titolo Pubblicato in Anno
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study ATHEROSCLEROSIS 2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions DRUGS 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg? ATHEROSCLEROSIS 2025
Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly DRUGS 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data JOURNAL OF CLINICAL LIPIDOLOGY 2025
Lomitapide-induced fatty liver is a reversible condition: evidence from a case of familial chylomicronemia syndrome JOURNAL OF CLINICAL LIPIDOLOGY 2025
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia JAMA CARDIOLOGY 2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries EUROPEAN JOURNAL OF INTERNAL MEDICINE 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2024
Is bempedoic acid a drug for female subjects? Preliminary analysis in an Italian cohort ATHEROSCLEROSIS 2024
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2024
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment STAR PROTOCOLS 2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice? CURRENT ATHEROSCLEROSIS REPORTS 2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. LIVER INTERNATIONAL 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study LA RADIOLOGIA MEDICA 2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis CIRCULATION 2023
Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis CIRCULATION 2023
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2022
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study THE LANCET 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma